Sucampo Pharmaceuticals , Nasdaq: SCMP
Developer of proprietary drugs based on prostones to treat constipation.
Industry: Health Care
First Day Return: +6.6%
SCMP
Developer of proprietary drugs based on prostones to treat constipation.
| IPO Data | |
|---|---|
| IPO Date | 08/01/2007 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $43 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Bethesda, MD, United States |
| Founded | 1996 |
| Employees at IPO | n/a |
| Website www.sucampo.com | |
IPO News for Sucampo Pharmaceuticals
Sucampo Pharmaceuticals (SCMP) Performance
